Date | Insider | Price | Amount |
---|---|---|---|
1-22-2024 Insider Buy |
Young L. Robert |
$12.13 CAGR » |
$199,841.75 16,475 shares |
9-18-2017 Insider Buy |
William J. Schneider |
$17.33 CAGR » |
$400,343.79 23,100 shares |
8-24-2015 Insider Buy |
Jeffrey T. Schmitz |
$14.44 CAGR » |
$57,199.33 3,962 shares |
4-8-2015 Insider Buy |
Jeffrey T. Schmitz |
$17.26 CAGR » |
$69,044.22 4,000 shares |
Also See: Institutional Holders of JGH
Also See: SEC filings
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 01/23/2024 | ||
End date: | 05/08/2024 | ||
Start price/share: | $12.11 | ||
End price/share: | $12.85 | ||
Starting shares: | 825.76 | ||
Ending shares: | 846.54 | ||
Dividends reinvested/share: | $0.31 | ||
Total return: | 8.78% | ||
Annualized Gain: | 30.52% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $10,878.00 | ||
Years: | 0.29 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 01/23/2024 | ||
End date: | 05/08/2024 | ||
Start price/share: | $12.11 | ||
End price/share: | $12.85 | ||
Dividends collected/share: | $0.31 | ||
Total return: | 8.69% | ||
Annualized Gain: | 30.20% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $10,869.00 | ||
Years: | 0.29 |
Nuveen Global High Income Fund Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Nuveen Global High Income Fund insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding JGH
Free JGH Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Nuveen Global High Income Fund Insider Buying occurred are:
Assembly Biosciences Insider Buying |